C. H. L. Shackleton

5 α-reductase activity in polycystic ovary syndrome

Paul M. Stewart, Christopher R.W. Edwards, C. H. L. Shackleton et al. · The Lancet · 1990 · 190 citations

Medicine, Biochemistry, Endocrinology +13

11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Lean and Obese Males with Type 2 Diabetes Mellitus

George Valsamakis, A Anwar, Jeremy Tomlinson et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 156 citations · Full text

Life Sciences, Endocrinology, Physiology +14

Molecular Basis for Hypertension in the “Type II Variant” of Apparent Mineralocorticoid Excess

Aoxiang Li, R Tedde, Z. Krozowski et al. · The American Journal of Human Genetics · 1998 · 108 citations · Full text

Medicine, Endocrinology, Molecular Medicine +15

Living donor liver transplantation: Histological abnormalities found on liver biopsies of apparently healthy potential donors

Tram T. Tran, Chanikarn Changsri, C. H. L. Shackleton et al. · Journal of Gastroenterology and Hepatology · 2006 · 83 citations

Medicine, Pathology, Hepatology +16

Dehydroepiandrosterone sulfate quantification in serum using high-performance liquid chromatography/ mass spectrometry and a deuterated internal standard: a technique suitable for routine use or as a reference method

C. H. L. Shackleton, C. Kletke, Stefan A. Wudy et al. · Steroids · 1990 · 55 citations

Life Sciences, Biochemistry, Endocrinology +17